Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
出版年份 2017 全文链接
标题
Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile
Infection
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 37, Issue 10, Pages 1298-1308
出版商
Wiley
发表日期
2017-07-21
DOI
10.1002/phar.1990
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis
- (2017) Nicole T. Shen et al. GASTROENTEROLOGY
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
- (2016) Colleen R. Kelly et al. ANNALS OF INTERNAL MEDICINE
- Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
- (2016) Swati B. Gupta et al. CLINICAL INFECTIOUS DISEASES
- New and emerging therapies for Clostridium difficile infection
- (2016) Jessica Martin et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Bezlotoxumab: First Global Approval
- (2016) Anthony Markham DRUGS
- Impact of Clostridium difficile recurrence on hospital readmissions
- (2015) Margaret A. Olsen et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
- (2015) Casey M. Theriot et al. Annual Review of Microbiology
- Clinical and Healthcare Burden of Multiple Recurrences ofClostridium difficileInfection
- (2015) Caroline Sheitoyan-Pesant et al. CLINICAL INFECTIOUS DISEASES
- Recurrent Clostridium difficile infection is associated with increased mortality
- (2015) M.A. Olsen et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
- (2015) Jennie H. Kwon et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use
- (2014) Judith Maria Wenisch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted byIn VitroNeutralization and Epitope Modeling
- (2014) Lorraine D. Hernandez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
- (2014) Marya D Zilberberg et al. BMC INFECTIOUS DISEASES
- Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile
- (2014) Robert A. Britton et al. GASTROENTEROLOGY
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
- (2014) Erik R. Dubberke et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Mechanism of Action and Epitopes ofClostridium difficileToxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
- (2014) Peter Orth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
- (2013) Hon Wai Koon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clostridium difficile Ribotype Does Not Predict Severe Infection
- (2012) Seth T. Walk et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Failures in Recurrent Clostridium difficile Infection: A Problem of Timing
- (2012) R. Orenstein CLINICAL INFECTIOUS DISEASES
- Burden of Clostridium difficile on the Healthcare System
- (2012) Erik R. Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology, diagnosis and treatment ofClostridium difficileinfection
- (2012) Matteo Bassetti et al. Expert Review of Anti-Infective Therapy
- An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings
- (2012) M. A. Aldeyab et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Association of Relapse of Clostridium difficile Disease with BI/NAP1/027
- (2012) J. W. Marsh et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease
- (2012) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- Clostridium difficile Toxins: Mediators of Inflammation
- (2012) Aimee Shen Journal of Innate Immunity
- Immune responses to Clostridium difficile infection
- (2012) Rajat Madan et al. TRENDS IN MOLECULAR MEDICINE
- Fecal microbiota transplantation in relapsing Clostridium difficile infection
- (2012) Faith Rohlke et al. Therapeutic Advances in Gastroenterology
- Mechanisms of Monoclonal Antibody–Drug Interactions
- (2011) Honghui Zhou et al. Annual Review of Pharmacology and Toxicology
- Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection
- (2011) Caitlin R. Musgrave et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea
- (2010) Kjetil Garborg et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Recurrent Clostridium difficile infection: causality and therapeutic approaches
- (2009) Stuart Johnson INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clostridium difficile infection: new developments in epidemiology and pathogenesis
- (2009) Maja Rupnik et al. NATURE REVIEWS MICROBIOLOGY
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Antimicrobial‐Associated Risk Factors forClostridium difficileInfection
- (2008) Robert C. Owens et al. CLINICAL INFECTIOUS DISEASES
- Measures to Control and PreventClostridium difficileInfection
- (2008) Dale N. Gerding et al. CLINICAL INFECTIOUS DISEASES
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now